What patients and providers should understand about economic evaluations in oncology
- PMID: 23180987
- PMCID: PMC3396819
- DOI: 10.1200/JOP.2012.000612
What patients and providers should understand about economic evaluations in oncology
Comment on
-
Proposal for a novel methodology to screen and score cost versus survival for anticancer drugs in metastatic disease: could cost weigh in evaluation?J Oncol Pract. 2012 Jul;8(4):224-30. doi: 10.1200/JOP.2011.000390. J Oncol Pract. 2012. PMID: 23180986 Free PMC article.
References
-
- American Cancer Society. Cancer facts and figures 2011. www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/doc....
-
- Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. PharmacoEconomics. 1998;13:397–409. - PubMed
-
- Drummond MF, Stoddart GL. Economic analysis and clinical trials. Contr Clin Trials. 1984;5:115–128. - PubMed
-
- Ramsey S, Willke R, Briggs A, et al. Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA Task Force report. Value Health. 2005;8:521–33. - PubMed
-
- Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the Economic Evaluation of Health Care Programmes. ed 3. London, United Kingdom: Oxford Medical Publications; 2005.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
